Published in Am J Cardiol on October 01, 2003
Psychobiology of depression/distress in congestive heart failure. Heart Fail Rev (2008) 0.92
Heart-brain interactions in mental stress-induced myocardial ischemia. Curr Cardiol Rep (2009) 0.90
Effect of Acute Mental Stress on Heart Rate and QT Variability in Postmyocardial Infarction Patients. ISRN Cardiol (2012) 0.79
Can we trigger an acute coronary syndrome? Heart (2006) 0.77
Increased Likelihood of Arrhythmic Events Associated with Increased Anxiety in Patients with Implanted Cardiac Defibrillators after the Ahar-Varzegan Earthquake in East Azarbaijan, 2012. Bull Emerg Trauma (2016) 0.75
Lack of increase of cerebrovascular events during German World Cup soccer games in 2006. J Neurol (2009) 0.75
Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med (2005) 13.96
Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics (2002) 9.87
Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med (2010) 6.86
Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol (2007) 6.68
Early CPAP versus surfactant in extremely preterm infants. N Engl J Med (2010) 5.23
Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation (2003) 5.20
Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med (2002) 4.62
Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation (2005) 4.03
Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol (2002) 3.79
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol (2005) 3.15
Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics (2006) 3.13
Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics (2005) 3.06
Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics (2006) 2.98
Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med (2005) 2.81
Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2012) 2.78
Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998. Pediatrics (2005) 2.61
Center differences and outcomes of extremely low birth weight infants. Pediatrics (2004) 2.56
Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics (2004) 2.41
Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics (2006) 2.41
No-reflow phenomenon. Circulation (2002) 2.30
Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999. Pediatrics (2005) 2.09
Cardiovascular effects of cocaine. Circulation (2010) 2.05
Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age. Pediatrics (2007) 2.03
Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. J Am Coll Cardiol (2008) 2.02
Clinical seizures in neonatal hypoxic-ischemic encephalopathy have no independent impact on neurodevelopmental outcome: secondary analyses of data from the neonatal research network hypothermia trial. J Child Neurol (2010) 1.87
Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol (2005) 1.83
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83
Interobserver reliability and accuracy of cranial ultrasound scanning interpretation in premature infants. J Pediatr (2007) 1.79
Laparotomy versus peritoneal drainage for necrotizing enterocolitis or isolated intestinal perforation in extremely low birth weight infants: outcomes through 18 months adjusted age. Pediatrics (2006) 1.69
Comparison of automated oscillometric versus auscultatory blood pressure measurement. Am J Cardiol (2010) 1.66
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66
Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J (2012) 1.65
The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics (2004) 1.61
Extremely low birthweight neonates with protracted ventilation: mortality and 18-month neurodevelopmental outcomes. J Pediatr (2005) 1.61
To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics (2004) 1.56
Human milk intake and retinopathy of prematurity in extremely low birth weight infants. Pediatrics (2007) 1.53
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med (2006) 1.53
Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med (2008) 1.49
Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev (2011) 1.49
Role of age, sex, and race on cardiac and total mortality associated with Super Bowl wins and losses. Clin Cardiol (2011) 1.48
Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res (2005) 1.48
Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation. Cardiovasc Res (2003) 1.47
The "no-reflow" phenomenon: basic science and clinical correlates. Heart (2002) 1.46
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. J Am Coll Cardiol (2005) 1.46
Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J Mol Cell Cardiol (2003) 1.46
The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension. J Clin Hypertens (Greenwich) (2003) 1.44
High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience. J Invasive Cardiol (2011) 1.43
Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease. Circulation (2011) 1.39
Elevated temperature after hypoxic-ischemic encephalopathy: risk factor for adverse outcomes. Pediatrics (2008) 1.39
Rotational atherectomy in the drug-eluting stent era: a single-center experience. J Invasive Cardiol (2011) 1.38
Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol (2008) 1.35
The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol (2006) 1.32
Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation (2002) 1.32
Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol (2009) 1.29
A 4-year update on the safety of sildenafil citrate (Viagra). Urology (2002) 1.28
Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics (2004) 1.27
Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv (2008) 1.24
Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol (2007) 1.23
Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med (2003) 1.22
Predictive value of an early amplitude integrated electroencephalogram and neurologic examination. Pediatrics (2011) 1.21
Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction. Cardiovasc Res (2003) 1.20
Spectrum of gross motor function in extremely low birth weight children with cerebral palsy at 18 months of age. Pediatrics (2005) 1.18
Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. Circulation (2003) 1.16
An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol (2012) 1.16
Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. J Endocrinol (2007) 1.14
Cardiac uses of phosphodiesterase-5 inhibitors. J Am Coll Cardiol (2012) 1.13
Coronary no reflow. J Mol Cell Cardiol (2011) 1.12
Review of vascular closure devices. J Invasive Cardiol (2010) 1.11
Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med (2007) 1.08
Maternal age, multiple birth, and extremely low birth weight infants. J Pediatr (2008) 1.06
Genetic contributors toward increased risk for ischemic heart disease. J Mol Cell Cardiol (2005) 1.04
Sporting events affect spectators' cardiovascular mortality: it is not just a game. Am J Med (2010) 1.03
Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2009) 1.02
Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. J Pediatr (2002) 1.02
No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation (2003) 1.00
Long-term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function. J Mol Cell Cardiol (2003) 1.00
Interactions between maternal characteristics and neonatal behavior in the prediction of parenting stress and perception of infant temperament. J Pediatr Psychol (2005) 0.99
Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment. Life Sci (2008) 0.99
Twin gestation and neurodevelopmental outcome in extremely low birth weight infants. Pediatrics (2009) 0.99
Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair. Circulation (2002) 0.99
Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol (2002) 0.99
Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol (2002) 0.99
Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy. J Biol Chem (2009) 0.98
Peripheral chronic total occlusions treated with subintimal angioplasty and a true lumen re-entry device. J Invasive Cardiol (2009) 0.98
Community supports after surviving extremely low-birth-weight, extremely preterm birth: special outpatient services in early childhood. Arch Pediatr Adolesc Med (2008) 0.98
No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol (2010) 0.97
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. J Urol (2013) 0.97
Cocaine-induced acute myocardial infarction. Clin Med Res (2007) 0.96
Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc (2013) 0.96
A repeated measures approach for simultaneous modeling of multiple neurobehavioral outcomes in newborns exposed to cocaine in utero. Am J Epidemiol (2004) 0.96
Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med (2009) 0.95
Transthoracic echocardiography in rats. Evalution of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging. Basic Res Cardiol (2003) 0.95
Major congenital anomalies place extremely low birth weight infants at higher risk for poor growth and developmental outcomes. Pediatrics (2007) 0.95
Sildenafil in patients with cardiovascular disease. Am J Cardiol (2003) 0.93
Particulate air pollution and coronary heart disease. Curr Opin Cardiol (2009) 0.93
Real-time intravascular shear stress in the rabbit abdominal aorta. IEEE Trans Biomed Eng (2009) 0.93
Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension. Circulation (2010) 0.93
Cardioprotection of insulin-like growth factor-1 during reperfusion therapy: what is the underlying mechanism or mechanisms? Circ Cardiovasc Interv (2011) 0.93